Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...
The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease. The US FDA this week approved the sale of the treatment, which ...
A disrupted protein degradation process in heart muscle cells can lead to a range of severe heart diseases. In the case of dilated cardiomyopathy, a pathological enlargement of the heart chambers ...
Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' (SUPN.O), opens new tab drug-device combination to treat movement-related symptoms of Parkinson's ...
On Thursday, Jan. 30, the "Walking in Memphis" hitmaker posted about his Parkinson's disease diagnosis on Instagram and explained why he is sharing the news years later. "I feel like it's time to ...
About 5 years ago, I was diagnosed with Parkinson’s disease. I waited this long to tell you about the diagnosis because I needed time to process the unsettling news myself. But the good news is ...
Kevin Hill said he is able to go for days now without thinking about his Parkinson's A man fitted with a pioneering, computer-controlled brain implant to tackle his Parkinson's disease says it ...
A man fitted with a pioneering, computer-controlled brain implant to tackle his Parkinson's disease says it works so well he is sometimes able to forget he has the condition. A small computer ...
He attributed the need to drop out to the effects of Parkinson’s disease on his playing. “It is with profound regret that, due to performance issues associated with my recently diagnosed ...
Smith, who has toured with the "Hotel California" hitmakers since 2001, is bowing out of the group for now amid a battle with Parkinson's disease. “It is with profound regret that, due to ...
A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target for suppressing endothelial inflammation and atherosclerosis.